Medications know to cause bone marrow suppression (e.g., myelosuppressive antineoplastic agents) may result in a blunted or impeded response to methylcobalamin, vitamin B12 therapy
However, significant or rapid rises in PSA during testosterone therapy warrant further investigation to rule out other causes
E., Vassall, S., Kaur, G., Lewis, C., Karim, M., & Rossignol, D
Now that Medicare will cover Wegovy, many other drug manufacturers will also look to get approval of additional anti-obesity medications if they can demonstrate their benefits beyond weight loss
Removing more fat than this dramatically increases the risk of blood loss and severe fluid shifts
Even more striking, 33.7% reported complete resolution of at least one symptom